Tag: Sunovion Pharmaceuticals

Lupin rolls out Lurasidone Hydrochloride in US for bipolar depression

businessnewstoday- February 22, 2023

Lupin Limited said that it has rolled out Lurasidone Hydrochloride Tablets in the strengths of 20mg, 40mg, 60mg, 80mg, and 120mg in the US. Lurasidone ... Read More

Lupin to acquire rights to Brovana and Xopenex HFA for $75m

businessnewstoday- October 20, 2022

Lupin Limited has agreed to acquire all rights to a couple of inhalation medicines, namely Brovana (arformoterol tartrate) Inhalation Solution and Xopenex HFA (levalbuterol tartrate) ... Read More

Lupin Limited launches generic of Arformoterol Tartrate in US

pallavi123- June 4, 2021

Lupin Limited said that it has launched the authorized generic version of Brovana (arformoterol tartrate) Inhalation Solution 15 mcg /2 mL, unit-dose vials, of Sunovion ... Read More

Alembic Pharmaceuticals gets FDA approval for Lurasidone Hydrochloride Tablets

pallavi123- May 14, 2021

Alembic Pharmaceuticals has secured final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Lurasidone Hydrochloride Tablets, ... Read More

FDA refuses to approve Sunovion ADHD drug dasotraline

pharmanewsdaily- September 2, 2018

FDA decision on Sunovion ADHD drug approval : The US Food and Drug Administration (FDA) has refused to approve Sunovion Pharmaceuticals’ dual-acting dopamine and norepinephrine ... Read More